LORNOXICAM-LOADED NANOSPONGES FOR CONTROLLED ANTI-INFLAMMATORY EFFECT: IN VITRO/ IN VIVO ASSESSMENT

Nanosponges for controlled release

  • Heba Eassa Al-Azhar University-Faculty of Pharmacy
  • Seham Shawky
  • Seham Shawky
  • Maha Ahmed
  • Maha Ahmed

Abstract

The study aim was to design a controlled topical delivery system of lornoxicam (LX) to enhance skin permeation and treatment efficacy. Nanosponges were chosen as novel carrier for this purpose.  Nanosponges were formulated via emulsion solvent evaporation method using ethyl cellulose (polymer) and polyvinyl alcohol (surfactant). Nanosponge dispersions were characterized for colloidal properties, entrapment efficiency and in vitro release study. The nanosponge formulation (LS1) was then incorporated into carboxymethyl cellulose sodium hydrogels and evaluated for pH, viscosity and in vitro drug release. Skin irritation was evaluated, and anti-inflammatory activity was assessed via rat hind paw edema method. Nanosponges were in the nano-sized range and attained a uniform round shape with a spongy structure. LS1exhibited the highest LX release after 6 h, so it was incorporated as hydrogel. In vivo study revealed an enhanced anti-inflammatory activity for 6 h (p < 0.001). It can be deduced that the developed nanosponge hydrogel is an efficient nanocarrier for improved and controlled topical delivery of LX.

Keywords: Ethyl cellulose, lornoxicam, Nanosponge, Anti-inflammatory, Topical delivery

References

1. Helmy HS, El-Sahar AE, Sayed RH, Shamma RN, Salama AH, Elbaz EM. Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis. Int J Nanomed. 2017;12:7015-23. Epub 2017/10/14. doi: 10.2147/ijn.S147738. PubMed PMID: 29026298; PubMed Central PMCID: PMCPMC5626385.
2. Zaid AN, Mousa A, Jaradat N, Bustami R. Lornoxicam Immediate-Release Tablets: Formulation and Bioequivalence Study in Healthy Mediterranean Volunteers Using a Validated LC-MS/MS Method. Clin Pharmacol Drug Dev. 2017;6(6):564-9. Epub 2017/02/09. doi: 10.1002/cpdd.333. PubMed PMID: 28176487.
3. Gadade D, Kulkarni D, Rathi P, Pekamwar S, Joshi S. Solubility Enhancement of Lornoxicam by Crystal Engineering. Indian J Pharm Sci. 2017;79:277-86. doi: 10.4172/pharmaceutical-sciences.1000226.
4. Nijhawan M, Santhosh A, Babu PR, Subrahmanyam CV. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization. Drug development and industrial pharmacy. 2014;40(9):1163-72. Epub 2013/07/09. doi: 10.3109/03639045.2013.804834. PubMed PMID: 23829186.
5. Marzouk M, Ammar A, Darwish M, Ali H. Preformulation, Development and in-vitro Study of Bilayer Tablets of Lornoxicam. Asian J Pharm Health Sci. 2017;7(4).
6. Dasgupta S, Ghosh SK, Ray S, Kaurav SS, Mazumder B. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application. Curr Drug Delivery. 2014;11(1):132-8. Epub 2013/11/26. doi: 10.2174/15672018113106660063. PubMed PMID: 24266509.
7. Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: a review. Acta pharmaceutica (Zagreb, Croatia). 2013;63(3):335-58. Epub 2013/10/25. doi: 10.2478/acph-2013-0021. PubMed PMID: 24152895.
8. Khalifa MKA, Salem HA, Shawky SM, Eassa HA, Elaidy AM. Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients. Drug Delivery. 2019;26(1):1243-53. Epub 2019/11/23. doi: 10.1080/10717544.2019.1687613. PubMed PMID: 31752566; PubMed Central PMCID: PMCPMC6882476.
9. Shringirishi M, Prajapati SK, Mahor A, Alok S, Yadav P, Verma A. Nanosponges: a potential nanocarrier for novel drug delivery-a review. Asian Pac J Trop Dis. 2014;4:S519-S26.
10. Trotta F, Dianzani C, Caldera F, Mognetti B, Cavalli R. The application of nanosponges to cancer drug delivery. Expert Opin on Drug Delivery. 2014;11(6):931-41.
11. Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system-review. Journal of Pharmacy & Pharmaceutical Sciences. 2012;15(1):103-11.
12. Aldawsari HM, Badr-Eldin SM, Labib GS, El-Kamel AH. Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: in vitro/in vivo evaluation. Int J Nanomed. 2015;10:893.
13. Haltner?Ukomadu E, Sacha M, Richter A, Hussein K. Hydrogel increases diclofenac skin permeation and absorption. Biopharm Drug Dispos. 2019;40(7):217-24.
14. Narayanaswamy R, Torchilin VP. Hydrogels and their applications in targeted drug delivery. Molecules. 2019;24(3):603.
15. Pushpalatha R, Selvamuthukumar S, Kilimozhi D. Cyclodextrin nanosponge based hydrogel for the transdermal co-delivery of curcumin and resveratrol: Development, optimization, in vitro and ex vivo evaluation. J Drug Deliv Sci Techno 2019;52:55-64.
16. Panday P, Shukla N, Sisodiya D, Jain V, Mahajan SC. Design and characterization of microsponge loaded controlled release epicutaneous gel of lornoxicam. Applied Medical Research. 2015;1(1):16-21.
17. Bhardwaj U, Burgess DJ. Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. Int J Pharm. 2010;388(1-2):181-9.
18. Al-Suwayeh SA, Taha EI, Al-Qahtani FM, Ahmed MO, Badran MM. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer. Sci World J. 2014;2014.
19. Das B, Nayak AK, Nanda U. Topical gels of lidocaine HCl using cashew gum and Carbopol 940: Preparation and in vitro skin permeation. Int J Biol Macromol. 2013;62:514-7. doi: https://doi.org/10.1016/j.ijbiomac.2013.09.049.
20. Osmani RAM, Kulkarni PK, Shanmuganathan S, Hani U, Srivastava A, Prerana M, et al. A 3 2 full factorial design for development and characterization of a nanosponge-based intravaginal in situ gelling system for vulvovaginal candidiasis. RSC advances. 2016;6(23):18737-50.
21. Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, et al. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Int J Nanomed. 2019;14:6135.
22. Moin A, Deb TK, Osmani RAM, Bhosale RR, Hani U. Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy. J Basic Clin Pharm. 2016;7(2):39.
23. Pawar P, Gholap A, Kuchekar A, Chellam B, Mali A. Formulation and Evaluation of Optimized Oxybenzone Microsponge Gel for Topical Delivery. J Drug Delivery. 2015;2015:1-9. doi: 10.1155/2015/261068.
24. Rajab NA, Jawad MS. Formulation and in vitro evaluation of piroxicam microsponge as a tablet. Int J Pharm Pharm Sci. 2016;8:104-14.
25. Jilsha G, Viswanad V. Nanosponge loaded hydrogel of cephalexin for topical delivery. Int J Pharm Sci Res. 2015;6(7):2781.
26. Anumolu PD, Sunitha G, Bindu SH, Satheshbabu PR, Subrahmanyam CVS. Development and validation of discriminating and biorelevant dissolution test for lornoxicam tablets. Indian J Pharm Sci. 2015;77(3):312.
27. Neela S, Uppuluri KB. Formulation and In-Vitro Evaluation of Piroxicam Loaded BSA Nanospheres by Desolvation. J Nanomed Nanotechnol. 2015;6(3):1.
28. Sharma R, Pathak K. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol. 2011;16(4):367-76.
29. Patel B, Bagade O, Ramteke K, Patel R, Awsarkar V. An Assessment on Preparations, Characterization, and Poles Apart Appliances of Nanosponge. Int J PharmTech Res. 2014;6:1898-907.
30. Bhandare CR, Katti SA. Formulation of microsponges of risperidone HCl. Int J Res Pharm Chem. 2016;6(3):518-27.
31. Aithal P A, Mulla K, Shabaraya A. Formulation And Evaluation Of Nanosponge Based Topical Gel Preparation Of Dapsone2019.
32. Patel J, Patel B, Banwait H, Parmar K, Patel M. Formulation and evaluation of topical aceclofenac gel using different gelling agent. Int J Drug Dev Res. 2011;3(1):156-64.
33. Abbas N, Parveen K, Hussain A, Latif S, uz Zaman S, Shah PA, et al. Nanosponge-based hydrogel preparation of fluconazole for improved topical delivery. Trop J Pharm Res. 2019;18(2):215-22.
Statistics
4 Views | Downloads
How to Cite
Eassa, H., Shawky, S., Shawky, S., Ahmed, M., & Ahmed, M. (2020). LORNOXICAM-LOADED NANOSPONGES FOR CONTROLLED ANTI-INFLAMMATORY EFFECT: IN VITRO/ IN VIVO ASSESSMENT. International Journal of Applied Pharmaceutics, 12(6). Retrieved from https://innovareacademics.in/journals/index.php/ijap/article/view/39430
Section
Original Article(s)